Antigen News and Research

RSS
COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

COVID-19 patient with repeatedly undetectable SARS-CoV-2 antibodies

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

Encouraging results from Phase I NovaVax SARS-CoV-2 nanoparticle vaccine trial

New platform shows potential to generate most effective vaccines with fewest side effects

New platform shows potential to generate most effective vaccines with fewest side effects

Scientists find new way of identifying and targeting hidden HIV viral reservoirs during ART therapy

Scientists find new way of identifying and targeting hidden HIV viral reservoirs during ART therapy

Study identifies five immune response markers that may predict COVID-19 patient outcomes

Study identifies five immune response markers that may predict COVID-19 patient outcomes

Gene could predict treatment response in certain breast cancer patients

Gene could predict treatment response in certain breast cancer patients

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Fujirebio announces launch of clinical testing for new SARS-CoV-2 Antigen assay

Avacta appoints COVID-19 rapid antigen test manufacturing partner

Avacta appoints COVID-19 rapid antigen test manufacturing partner

Cats susceptible to and potential reservoirs for novel coronavirus

Cats susceptible to and potential reservoirs for novel coronavirus

Eosinophils contribute to antiviral host defense mechanisms during influenza

Eosinophils contribute to antiviral host defense mechanisms during influenza

Evidence for antibody longevity in COVID-19 patients

Evidence for antibody longevity in COVID-19 patients

Study shows the strategies tumor cells use to evade immune defense

Study shows the strategies tumor cells use to evade immune defense

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

NCI gives 'exceptional' rating to Penn's Abramson Cancer Center

Stabilized prefusion spike vaccine candidate induces powerful immune response

Stabilized prefusion spike vaccine candidate induces powerful immune response

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

New bivalent vaccine delivers robust cell-mediated and humoral immunity against SARS-CoV-2

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

Touchlight, Cancer Research UK and University of Southampton team up to develop DNA cancer vaccine

Touchlight, Cancer Research UK and University of Southampton team up to develop DNA cancer vaccine

New blood test can detect prostate cancer and confirm the stage of the disease

New blood test can detect prostate cancer and confirm the stage of the disease

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

Study finds synthetic neutralizing/enhancing antibodies to SARS-CoV-2

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women

SARS-CoV-2 exposure five times more likely among Black and Hispanic pregnant women